Your injectable frag 176-191 peptide will usually arrive as a lyophilized powder in a glass vial. Lyophilization preserves the biological activity of the peptide in a temperature-stable format, allowing shipment and extended shelf-life.
To prepare frag 176-191 for injection, researchers will need to reconstitute the lyophilized peptide with bacteriostatic water. This will dissolve the powder into a clear liquid that can be drawn up into a syringe.
Prior to reconstitution, ensure that a sufficient amount of bacteriostatic water is available. Note that bacteriostatic water is recommended for reconstitution, as it will protect the peptide against contamination for at least one month due to the presence of 0.9% benzyl alcohol.
Once bacteriostatic water is on hand, determine the volume needed to dilute the peptide to the desired concentration. Refer to the following protocol on how to complete reconstitution:
Clean hands and swab the rubber stopper on the frag 176-191 vial, as well as that of the bacteriostatic water vial.
Insert the needle into the bacteriostatic water vial and draw up the required volume of water.
Remove the syringe and insert it into the frag 176-191 vial, ensuring that the full volume of bacteriostatic water is dispensed prior to removal.
Gently rotate the frag 176-191 vial until the lyophilized powder is completely dissolved.
Once the peptide is reconstituted, keep the vial refrigerated.





